Transfer of health-related technologies to developing countries can enable recipient countries to produce the product locally and may result in increased access to the product and improved health. This technology transfer can take several forms, ranging from license agreements, provision of information, know-how and performance skills, to technical materials and equipment.
Publications on local production for access to medical products
The aim of this work was to develop a framework that could bring together and guide policymakers and others from all relevant fields to support the local production of medicines, vaccines and diagnostics in a manner that should improve access maximizing the potential to improve public health.
PHI’s role in transfer of health-related technology
Improving access to medicines in developing countries through technology transfer related to medical products and local production. There are two main streams of activity.
Technology transfer policy
- Commissioned research, workshops, analysis and reports
- Policy development identifying political, economic, social, technological, legal and environmental conditions that are conducive to successful technology transfer
Facilitating technology transfer
- Mapping of appropriate technologies and assessment of freedom-to-operate
- License negotiation on behalf of developing country manufacturers
- Establishment of centers of excellence to provide training and documentation on manufacturing processing
- Provision of technical support to developing country manufacturers
- Coordination of network of experts
- Training and capacity building
Meeting of Stakeholders for the “Development of a single dose malaria cure of artemether-lumefantrine through a nano-based drug delivery system"
- Survey: Global Strategy on Public Health, Innovation and Intellectual Property
Open-ended Meeting of WHO Member States
- Request for Proposals: Clinical Research Organization (CRO) to support Influenza Vaccine Clinical Trials in Serbia
Submission of an assessment report on the feasibility for establishing a pharmaceutical market data monitoring system in Ethiopia
WHO promotes, values and encourages health innovation
- Launch of Ethiopia’s National Strategy and Plan of Action for Pharmaceutical Manufacturing
- WHO publishes analysis of patent situation of new hepatitis treatments
- Follow-up of the report of the Consultative Expert Working Group on Research and Development:
ContactsPublic health, innovation, intellectual property and trade